2.16
+0.06(+2.86%)
Currency In USD
| Previous Close | 2.1 |
| Open | 2.11 |
| Day High | 2.16 |
| Day Low | 2.1 |
| 52-Week High | 8.27 |
| 52-Week Low | 1.72 |
| Volume | 12,076 |
| Average Volume | 82,651 |
| Market Cap | 4.32M |
| PE | -0.26 |
| EPS | -8.36 |
| Moving Average 50 Days | 2.22 |
| Moving Average 200 Days | 2.8 |
| Change | 0.06 |
If you invested $1000 in InMed Pharmaceuticals Inc. (INM) 10 years ago, it would be worth $0.97 as of October 20, 2025 at a share price of $2.16. Whereas If you bought $1000 worth of InMed Pharmaceuticals Inc. (INM) shares 5 years ago, it would be worth $1.23 as of October 20, 2025 at a share price of $2.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
InMed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
Newsfile
Oct 16, 2025 12:30 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseas
Inmed Pharmaceuticals Appoints Mr. John Bathery to Its Board of Directors
Newsfile
Oct 16, 2025 12:30 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - October 16, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseas
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors
Newsfile
Oct 09, 2025 12:30 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - October 9, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for disease